|
Masimo, a medical technology company that
designs pulse oximetry devices have filed a lawsuit against Apple accusing
the Cupertino company of stealing trade secrets and improperly using Masimo
inventions related to health monitoring in the Apple Watch.
Masimo claims that Apple stole secret
information by pretending to have a working relationship with Masimo, and then hiring Masimo employees. Masimo also believes the Apple Watch is
infringing on 10 Masimo patents.
Masimo, and its spinoff company Cercacor,
claim that Masimo's technology for non-invasive health monitoring helped
Apple overcomes performance issues with the Apple Watch. Apple allegedly
relied on Masimo tech when developing the light-based heart rate sensor used
in the Apple Watch, among other technologies.
According to Masimo, Apple first contacted the
company in 2013 and asked to meet for a potential collaboration, with Apple asking to "understand more" about Masimo's products to potentially integrate Masimo technology into future Apple devices. After what Masimo
considered productive meetings, Apple began hiring away important employees.
Ahead of when the Apple Watch was released,
Apple hired Michael O'Reilly, who had served as the Chief Medical Officer and
EVP of Medical Affairs at Masimo. He has been working on Health Special
Projects at Apple, and had a hand in the development of the Apple
Watch.
O'Reilly wasn't the only hire from Masimo, as
Apple also took on other former Masimo employees along with employees from other health-related companies during the time the Apple Watch was being designed. Marcelo Lamego, who served as CTO of Cercacor, for example, joined
Apple not long after O'Reilly.
Masimo says Apple received confidential
information from its hires, and launched a targeted effort to obtain
"information and expertise."
Masimo and Cercacor are aiming to block
further use of their patented inventions and are asking for unspecified damages. The two companies also want to add their engineers to four patents
that was granted to Lamego after leaving the Cercacor.
Masimo is a global medical technology company
focused on developing noninvasive patient monitoring features — with a
specific specialization in pulse oximeters. In 2014, ahead of the launch of
Apple Watch, various reports noted that Apple had hired executives from
Masimo.
|
Jenna Ortega, a successful American actress who rose to fame with the Wednesday series, has opened up about season 2 of Wednesday. Jenna Ortega, the show's leading lady, extensively spoke about Wednesday season 2. She talked about major updates on the genre of Season 2. She confirmed that season 2 contains horror elements. In an interview with Variety, the Wednesday actress stated, “We have decided that we want to lean into the horror aspect of the show a little bit more. Because it is so light-hearted, and a show like this with vampires and werewolves and superpowers, you don’t want to take yourself too seriously.” She said that season 2 ditched the idea of a love interest. In March this year, she confirmed the second season of Wednesday. She said that the series would focus more on horror and less on romance. In a Saturday Night Live episode, she said that the character of Wednesday Addams would be an individual going forward in the second season of the series. The ac...
Comments
Post a Comment